Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 188

    Shilpa Medicare gets USFDA approval for IRINOTECAN injection

    Shilpa Medicare gets USFDA approval for IRINOTECAN injection

    Farhat Nasim2 Jan 2019 9:15 AM IST
    Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added.New Delhi: Shilpa...
    Edwards Lifesciences gets USFDA nod to SAPIEN 3 Ultra Transcatheter Heart Valve

    Edwards Lifesciences gets USFDA nod to SAPIEN 3 Ultra Transcatheter Heart Valve

    Farhat Nasim2 Jan 2019 9:00 AM IST
    The SAPIEN 3 Ultra system builds on Edwards' decades of engineering and experience in the development of tissue heart valves, and the proven benefits...
    Fortis Healthcare appoints Shirish Moreshwar Apte as vice-chairman

    Fortis Healthcare appoints Shirish Moreshwar Apte as vice-chairman

    Farhat Nasim1 Jan 2019 11:03 AM IST
    The board of directors of the company has approved the appointment of Apte as an additional director designated as vice-chairman under the category of...
    Lupin receives FDA approval for Clobazam Oral Suspension

    Lupin receives FDA approval for Clobazam Oral Suspension

    Farhat Nasim1 Jan 2019 10:00 AM IST
    Lupin's Clobazam Oral Suspension, 2.5 mg/mL is the generic version of Lundbeck Pharmaceuticals, LLC's Onfi Oral Suspension, 2.5 mg/mL. It is indicated...
    SCHOTT KAISHA launches customizable prefillable glass syringes in India

    SCHOTT KAISHA launches customizable prefillable glass syringes in India

    Medical Dialogues Bureau1 Jan 2019 9:30 AM IST
    Rishad Dadachanji, Director, SCHOTT KAISHA shares, "The syriQ BioPure syringes, manufactured in St. Gallen, Switzerland, combine features to ensure...
    After damaging Reuters report, J&J doubles down on talc safety message

    After damaging Reuters report, J&J doubles down on talc safety message

    Farhat Nasim1 Jan 2019 9:15 AM IST
    To reassure investors and consumers, J&J has tweeted, posted on Facebook, run a series of full-page newspaper ads across the United States,...
    Zydus Cadila gets USFDA nod to market acne drug

    Zydus Cadila gets USFDA nod to market acne drug

    Medical Dialogues Bureau31 Dec 2018 1:14 PM IST
    New Delhi: Drug firm Zydus Cadila Saturday said it has received the final nod from the US health regulator to market Clindamycin Phosphate and Benzoyl...
    Cipla recalls 4,800 bottles of anti-HIV tablets from US

    Cipla recalls 4,800 bottles of anti-HIV tablets from US

    Medical Dialogues Bureau31 Dec 2018 9:12 AM IST
    Drug major Cipla is recalling 4,800 bottles of Nevirapine extended-release tablets used for the treatment of human immunodeficiency virus (HIV) from...
    Medtronic Completes Acquisition of Mazor Robotics

    Medtronic Completes Acquisition of Mazor Robotics

    Medical Dialogues Bureau30 Dec 2018 9:35 AM IST
    This acquisition strengthens Medtronic's position as a global innovator in enabling technologies for spine surgery. By combining Medtronic's...
    Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost

    Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost

    Medical Dialogues Bureau30 Dec 2018 9:20 AM IST
    ZURICH: Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan...
    Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi

    Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi

    Medical Dialogues Bureau30 Dec 2018 9:00 AM IST
    New Delhi: Through a press release, Opiant Pharmaceuticals recently announced that it has entered into an exclusive global licensing agreement with...
    Bal Pharma appoints S Anika Mercylin as CS, Compliance Officer

    Bal Pharma appoints S Anika Mercylin as CS, Compliance Officer

    Farhat Nasim29 Dec 2018 9:45 AM IST
    New Delhi: Drug major Bal Pharma recently appointed Ms S Anika Mercylin as the Company Secretary and Compliance Officer.The company stated in a BSE...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok